Related Experiment Videos
Amitriptyline action on sympathetic neuronal function in depressed women
G L Corona1, M L Cucchi, P Frattini
1Institute of Pharmacology, University of Pavia, Italy.
Clinical and Experimental Pharmacology & Physiology
|November 1, 1987
Summary
Amitriptyline treatment for depression in women lowered noradrenaline levels and altered cardiovascular function, suggesting reduced sympathetic tone. Elderly patients showed more pronounced blood pressure changes.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Neuroscience
Background:
- Depression is linked to altered noradrenergic activity.
- Amitriptyline is a common antidepressant affecting neurotransmitter systems.
- Orthostatic challenges reveal autonomic nervous system function.
Purpose of the Study:
- To investigate the effects of amitriptyline on noradrenaline levels and cardiovascular function during orthostatic stress in depressed female inpatients.
- To assess potential correlations between drug plasma levels, neurotransmitter changes, and cardiovascular responses.
Main Methods:
- 59 female inpatients with depression received intramuscular amitriptyline (100 mg daily) for 4 weeks.
- Cardiovascular parameters (pulse rate, blood pressure) were measured in supine and upright positions before and after orthostatic challenge.
- Plasma noradrenaline levels were quantified.
Main Results:
- Amitriptyline therapy increased pulse rate and decreased plasma noradrenaline levels.
- Significant modifications in systolic and diastolic blood pressure were observed, particularly in elderly subjects.
- No correlation was found between amitriptyline plasma levels and observed functional or neurotransmitter changes.
Conclusions:
- Amitriptyline treatment in depressed female inpatients appears to reduce sympathetic tone, indicated by lower noradrenaline levels and altered blood pressure responses.
- Cardiovascular adjustments to orthostatic challenge are modified by amitriptyline, with notable effects in the elderly.
- The findings suggest a complex interplay between amitriptyline, the noradrenergic system, and cardiovascular regulation in depression.